Past News

Purdue University engineers have now demonstrated a way to stop cancer from spreading throughout the pancreas by using a “time machine” they built.

December 14, 2021

To halt the progression of pancreatic cancer, scientists have created a “time machine” made of human cells.

Purdue University engineers have now demonstrated a way to stop cancer from spreading throughout the pancreas by using a “time machine” they built.

Purdue researchers develop quick test to spot most costly bovine disease

December 13, 2021

Purdue University researchers have developed a test that allows for quicker diagnosis and pinpointed treatment of bovine respiratory disease, the most common and costly disease affecting the world’s cattle.

Purdue researchers develop quick test to spot most costly bovine disease

Purdue Trustees Ratify Appointment of Dr. J. Paul Robinson as Distinguished Professor of Cytometry

December 10, 2021

The newest distinguished professor in the Purdue University College of Veterinary Medicine is Dr. J. Paul Robinson, a faculty member in the Department of Basic Medical Sciences and director of the Purdue University Cytometry Laboratories. The Purdue University Board of Trustees ratified Dr. Robinson’s appointment as Distinguished Professor of Cytometry last Friday, December 3.

Purdue Trustees Ratify Appointment of Dr. J. Paul Robinson as Distinguished Professor of Cytometry

Showalter Trust honors three new scholars, funds 11 early career faculty

December 10, 2021

Three Purdue faculty members – Mingji Dai, Haley Oliver and Yuan Yao – have been appointed as Showalter Faculty Scholars. As of July, they joined 11 additional Showalter Scholars appointed in prior years at Purdue West Lafayette. The Showalter Trust programs at Purdue also have named 11 early career faculty members for 2021 grants to support their research projects. The Ralph W. and Grace M. Showalter Research Trust Fund annually provides funding to Purdue in support of scientific and medical research. In addition to selecting midcareer professionals as Showalter Faculty Scholars and providing one-year funding for early career professionals, the trust also supports two Showalter Distinguished Professors at Purdue, Charles Bouman and Kinam Park.

Showalter Trust honors three new scholars, funds 11 early career faculty

Pen-side test for bovine respiratory disease could save industry millions

December 9, 2021

Sous-vide cooking inspired an idea that took promising technology out of the lab and into the barn. Researchers at Purdue University successfully developed an on-site bovine respiratory disease test that provides results within an hour.

Pen-side test for bovine respiratory disease could save industry millions

Catch bovine respiratory disease at the pen-side in as little as an hour

December 8, 2021

Detecting fatal repository disease in cattle is becoming quicker than ever with a new on-site testing method. A Purdue research team, led by assistant professor Mohit Verma, has successfully developed an easy-to-read test that produces results in as little as one hour.

Catch bovine respiratory disease at the pen-side in as little as an hour

The variant of hope: Omicron may help us end the pandemic and the coming weeks are crucial

December 8, 2021

omicron Just as the world tried starting to “live with Covid”, easing restrictions and reopening borders to international travel, emergence of a new variant in South Africa froze everything again. Is this never going to end? Are we bound to spend year after year under ever-changing pandemic restrictions, wearing masks, checking in to shopping malls, and getting regular vaccination boosters? Hopefully not and, paradoxically, Omicron may actually herald the beginning of the end of the pandemic and our return to normalcy. Few people may remember this now, but back in 2020 — long before we had vaccines and many expressed their skepticism about them ever being developed — scientists suggested that we should get ready for ongoing mutations of the virus, as it adapts to us and our environment. Those mutations, however, need not be more lethal. “…mutating to become more lethal to humans wouldn’t necessarily be in the virus’ best interests. If a virus goes in and immediately kills its host, that’s usually not very good because that limits its ability to expand and infect new hosts.” Richard Kuhn, a virologist and director of the Purdue Institute of Inflammation, Immunology and Infectious Disease in West Lafayette, Indiana, March 25, 2020 for Popular Science

The variant of hope: Omicron may help us end the pandemic and the coming weeks are crucial

Omicron can help us end the pandemic and the coming weeks are crucial – Health Guild News

December 8, 2021

Fight fire with fire When a virus gets worse, two things happen. First, potential guests are more willing to fight back (which is why we practice quarantine and treat patients in isolation rooms), so exposure to new guests is limited. Second, when the infected host dies, its ability to transmit the virus also ends. Therefore, from the perspective of the virus (especially one of the air), it is in their best interest to be able to infect as many people as possible. As a result, the strains that are most likely to be tolerated are those that are most infectious, but also the least severe. Natural selection is at stake here and a milder virus simply has a better chance of surviving in the environment. The appearance of this strain could help us beat the deadliest, in fact, use one viral sibling to eradicate the other. Scientists theorized that this may indeed be the case with Covid, as it is gradually evolving into a form that will not be worse than a common cold for most of us (after all, this is how many of us already suffer other human coronaviruses).

Omicron can help us end the pandemic and the coming weeks are crucial – Health Guild News

FDA Approves Purdue-Developed Drug for Ovarian Cancer Surgery

December 8, 2021

A drug used for fluorescent imaging during ovarian cancer surgeries, which was just approved by the FDA, lights up cancer cells “like stars against a night sky,” says Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry.

FDA Approves Purdue-Developed Drug for Ovarian Cancer Surgery

Pen-side test for bovine respiratory disease may save cattle industry millions, reduce antibiotic use

December 6, 2021

Sous-vide cooking has inspired an idea that took promising technology out of the lab and into the barn. Researchers at Purdue University have successfully developed an on-site bovine respiratory disease test that provides results within an hour.

Pen-side test for bovine respiratory disease may save cattle industry millions, reduce antibiotic use